The ablation of the matricellular protein EMILIN2 causes defective vascularization due to impaired EGFR-dependent IL-8 production affecting tumor growth
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The ablation of the matricellular protein EMILIN2 causes defective vascularization due to impaired EGFR-dependent IL-8 production affecting tumor growth
Authors
Keywords
-
Journal
ONCOGENE
Volume 37, Issue 25, Pages 3399-3414
Publisher
Springer Nature
Online
2018-02-23
DOI
10.1038/s41388-017-0107-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The angiostatic molecule Multimerin 2 is processed by MMP-9 to allow sprouting angiogenesis
- (2017) Eva Andreuzzi et al. MATRIX BIOLOGY
- Dissecting the CD93-Multimerin 2 interaction involved in cell adhesion and migration of the activated endothelium
- (2017) Federico Galvagni et al. MATRIX BIOLOGY
- Normalization of Tumor Vessels by Tie2 Activation and Ang2 Inhibition Enhances Drug Delivery and Produces a Favorable Tumor Microenvironment
- (2016) Jin-Sung Park et al. CANCER CELL
- Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy
- (2016) Anna Rita Cantelmo et al. CANCER CELL
- Targeting of EMILIN-1 and EMILIN-2 to Fibrillin Microfibrils Facilitates their Incorporation into the Extracellular Matrix
- (2016) Alvise Schiavinato et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Dual-Action Combination Therapy Enhances Angiogenesis while Reducing Tumor Growth and Spread
- (2015) Ping-Pui Wong et al. CANCER CELL
- Bad vessels beware! Semaphorins will sort you out!
- (2015) G. Serini et al. EMBO Molecular Medicine
- Metabolic and hypoxic adaptation to anti-angiogenic therapy: a target for induced essentiality
- (2015) A. McIntyre et al. EMBO Molecular Medicine
- Multiple-interactions among EMILIN1 and EMILIN2 N- and C-terminal domains
- (2015) Simonetta Bot et al. MATRIX BIOLOGY
- Genetic compensation induced by deleterious mutations but not gene knockdowns
- (2015) Andrea Rossi et al. NATURE
- MULTIMERIN2 binds VEGF-A primarily via the carbohydrate chains exerting an angiostatic function and impairing tumor growth
- (2015) Roberta Colladel et al. Oncotarget
- The Extracellular Matrix Glycoprotein Elastin Microfibril Interface Located Protein 2: A Dual Role in the Tumor Microenvironment
- (2015) Maurizio Mongiat et al. NEOPLASIA
- Tumor Vessel Normalization by Chloroquine Independent of Autophagy
- (2014) Hannelore Maes et al. CANCER CELL
- Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
- (2014) Rakesh K. Jain CANCER CELL
- Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway
- (2014) Ji Zhou et al. CELLULAR SIGNALLING
- EMILIN2 down-modulates the Wnt signalling pathway and suppresses breast cancer cell growth and migration
- (2013) Stefano Marastoni et al. JOURNAL OF PATHOLOGY
- Bevacizumab in Stage II-III Colon Cancer: 5-Year Update of the National Surgical Adjuvant Breast and Bowel Project C-08 Trial
- (2012) Carmen J. Allegra et al. JOURNAL OF CLINICAL ONCOLOGY
- G-CSF-activated STAT3 enhances production of the chemokine MIP-2 in bone marrow neutrophils
- (2012) Hoainam T. Nguyen-Jackson et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Interleukin-8 and CXCL10 expression in oral keratinocytes and fibroblasts via Toll-like receptors
- (2012) Akiko Fukui et al. MICROBIOLOGY AND IMMUNOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
- (2011) Atsushi Ohtsu et al. JOURNAL OF CLINICAL ONCOLOGY
- The requirement for fibroblasts in angiogenesis: fibroblast-derived matrix proteins are essential for endothelial cell lumen formation
- (2011) Andrew C. Newman et al. MOLECULAR BIOLOGY OF THE CELL
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320
- (2011) A. Bronisz et al. NATURE CELL BIOLOGY
- MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway
- (2011) E Lorenzon et al. ONCOGENE
- A chemotactic gradient sequestered on endothelial heparan sulfate induces directional intraluminal crawling of neutrophils
- (2010) S. Massena et al. BLOOD
- Ontology-Based Meta-Analysis of Global Collections of High-Throughput Public Data
- (2010) Ilya Kupershmidt et al. PLoS One
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
- (2009) John M.L. Ebos et al. CANCER CELL
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization
- (2009) Massimiliano Mazzone et al. CELL
- The biological properties of cetuximab
- (2008) Bruno Vincenzi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Emilin1 Deficiency Causes Structural and Functional Defects of Lymphatic Vasculature
- (2008) C. Danussi et al. MOLECULAR AND CELLULAR BIOLOGY
- EMILINs interact with anthrax protective antigen and inhibit toxin action in vitro
- (2007) Roberto Doliana et al. MATRIX BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started